Unique in its composition with extracts from the three wild Aronia species and big-fruited Aronia.
Documented in clinical trials at Danish hospital.
We have just published the results from the Clinical trial “SUND” on the health effects of our Aronia composition ARO3:5® in Journal of Clinical Medicine. The clinical trial had 109 male participants and has been a collaboration between a range of MD´s, Professors and scientists from the regional Hopital Horsens, Odense University Hospital, University of Southern Denmark, Chr. Hansen A/S and Byrial ApS.
The trial design is a so-called golden standard design performed as a cross-over, double blinded, randomized study. This means that all participants over a period of 270 days have received both placebo and Aronia (blinded) capsules in two 90 days treatment periods separated by a 90 days washout period. Due to the EU rules we are not allowed to show the results from the study at our home page until we get a formal permission from EFSA. This application process may take a year or so from now, but you are welcome to search for the paper which is available online for free via Journal of Clinical Medicine.
Our Aronia powder composition, ARO3:5®, has been developed over the last 10 years by Byrial ApS and comprise the bioactive compounds from the three wild species of Aronia mixed with the big-fruited Aronia.
This mixture, ARO3:5®, is standardized according to the content of a total anthocyanins and comprise the three wild Aronia spp: Aronia arbutifolia var. Virinia, Aronia prunifolia var. Vikilia, and Aronia melanocarpa var. Swecia and the cultivated Aronia hybrid × Sorbaronia mitschurinii var Roar all developed via 18.000 controlled crossings at at Byrial Aps´s laboratory and research farm in Lejre Denmark.
Please contact Henrik Byrial ( firstname.lastname@example.org +45 22 61 10 66) for further information